Background Cost-of-illness (COI) studies of Multiple Sclerosis (MS) are vital components for
describing the economic burden of MS, and are frequently used in model studies of …

The number of cost-of-illness (COI) studies has expanded considerably over time. One
outcome of this growth is that the reported COI estimates are inconsistent across studies …

Costs of disorders of the brain in Europe EUROPEAN JOURNAL OF NEUROLOGY Volume 12,
Supplement 1, June 2005 Costs of Disorders of the Brain in Europe Guest Editors: Patrik …

Objective: To assess overall resource consumption, work capacity and quality of life of
patients with multiple sclerosis in nine European countries. Methods: Information on …

The Sonya Slifka Longitudinal Multiple Sclerosis Study follows a population-based cohort of
approximately 2000 people with multiple sclerosis (MS) to study demographic and clinical …

Multiple sclerosis (MS) is a disease of the CNS, typically striking adults during the primary
productive time of their life. The symptoms of MS can restrict the individual's physical activity …

Objective: To estimate current costs and quality of life (utility) of patients treated with disease
modifying drugs (DMDs) in the United States, and to investigate the effect of disease severity …

Objective: Debilitating pain, occurring in 50–70% of multiple sclerosis (MS) patients, is
poorly understood and infrequently studied. We summarized efficacy and safety data of …

Assistive technology makes up a substantial portion of the direct cost of multiple sclerosis
(MS). Equipment abandonment results in the needs of the disabled individual being unmet …

Background Rheumatic diseases have an economic impact of 1–2.5% of GDP in
industrialized countries and osteoarthritis is the most common joint disorder. Osteoarthritis of …